World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...

CytoMed has generated the critical cell banks for the iPSC-derived hybrid of gamma delta T and Natural Killer cell technology and is currently undergoing process development into a potentially very ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company") today released a letter to shareholders from the Chairman of the Company's Board ...

Farid Adrienne, the Chief Operations Officer of Century Therapeutics , Inc. (NASDAQ:IPSC), recently sold shares of the ...

Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...

利用存在严重印记缺陷且通常无法存活的双父本小鼠胚胎，研究团队在20个关键印记位点引入了移码突变、基因缺失和调控区域编辑，制定出了一种策略，能够有效解决双父本胚胎中最严重的发育缺陷。这种方法通过胚胎干细胞互补、单倍体细胞核注射以及体细胞核移植（SCNT），最终成功培育出了能够完全成年的双父本小鼠（孤雄小鼠）。